Gain Therapeutics News - GANX

Company Name	Stock Ticker Symbol	Market	Type
Gain Therapeutics Inc	GANX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	3.07	05:42:51

Open Price	Low Price	High Price	Close Price	Prev Close
				3.07

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/24/2024	09:25	GLOBE	Gain Therapeutics Announces Positive Results from the Single..
4/08/2024	09:25	GLOBE	Gain Therapeutics Bolsters Management Team with the..
4/01/2024	09:25	GLOBE	Gain Therapeutics Strengthens Management Team and Appoints..
3/26/2024	08:00	GLOBE	Gain Therapeutics Reports Financial Results for Year End..
3/15/2024	14:30	GLOBE	Gain Therapeutics to Present at Public Ventures Discovery..
3/05/2024	08:00	GLOBE	Gain Therapeutics Presents Data at the AD/PD™ 2024..
2/27/2024	14:00	GLOBE	Gain Therapeutics Announces the Initiation of the Multiple..
2/22/2024	07:00	EDGAR2	Form 8-K - Current report
2/14/2024	12:29	GLOBE	Gain Therapeutics Announces 2024 R&D Update on Parkinson’s..
2/06/2024	09:56	GLOBE	UPDATE - Gain Therapeutics’ GT-02287 Completely Restores..
2/06/2024	08:00	GLOBE	Gain Therapeutics’ GT-02287 Completely Restores Motor..
1/31/2024	17:26	EDGAR2	Form 8-K - Current report
1/31/2024	08:00	GLOBE	Gain Therapeutics’ CEO Matthias Alder Issues Letter to..
1/02/2024	16:09	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
1/02/2024	08:00	GLOBE	Gain Therapeutics Announces Acceptance of Late-Breaking..
1/02/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
12/19/2023	16:52	EDGAR2	Form S-1 - General form for registration of securities under..
12/01/2023	08:00	GLOBE	Gain Therapeutics Announces Preclinical Data Showing..
11/29/2023	08:00	GLOBE	Gain Therapeutics to Participate in AI Driven Drug Discovery..
11/24/2023	13:01	GLOBE	Gain Therapeutics Announces Closing of $10.1 Million Public..
11/24/2023	06:07	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/22/2023	17:27	EDGAR2	Form 8-K - Current report
11/21/2023	08:54	GLOBE	Gain Therapeutics Announces Pricing of $9.4 Million Public..
11/20/2023	16:22	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/20/2023	16:03	GLOBE	Gain Therapeutics Announces Proposed Public Offering
11/17/2023	16:27	EDGAR2	Form 8-K - Current report
11/14/2023	16:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/14/2023	16:02	EDGAR2	Form 8-K - Current report
11/14/2023	07:00	GLOBE	Gain Therapeutics Announces Third Quarter 2023 Financial..
10/04/2023	07:00	GLOBE	Gain Therapeutics Announces Dosing of First Two Subjects in..
9/25/2023	16:05	GLOBE	Gain Therapeutics to Participate at Cantor Fitzgerald Global..
9/20/2023	16:05	GLOBE	Gain Therapeutics to Present at the Cambridge Healthtech..
9/12/2023	09:25	GLOBE	Gain Therapeutics Receives Approval to Commence Phase 1..
8/10/2023	16:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	16:02	EDGAR2	Form 8-K - Current report
8/10/2023	07:00	GLOBE	Gain Therapeutics Announces Second Quarter 2023 Financial..
8/07/2023	07:00	GLOBE	Gain Therapeutics Announces Acceptance of Late Breaking..
7/31/2023	08:00	GLOBE	Gain Therapeutics to Participate in the 2023 BTIG Virtual..
6/01/2023	08:00	GLOBE	Gain Therapeutics to Present at the Jefferies Healthcare..
5/12/2023	08:00	GLOBE	Gain Therapeutics Reports First Quarter 2023 Financial..
5/03/2023	09:15	GLOBE	Gain Therapeutics Awarded CHF 2.5 million Innosuisse Grant..